Loading
Life sciences · Journal article
Gut Microbes · September 10, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Probiotic and live biotherapeutic interventions frequently yield inconsistent clinical benefits despite strong mechanistic rationale and widespread use. We propose that this heterogeneity reflects the ecological state of the gut at the time of dosing, in which an introduced strain must invade an already occupied ecosystem shaped by host physicochemical filters and resident community interactions. We introduce microbial niche tension as a trial-operational state variable capturing the net impedance to engraftment imposed by exclusionary forces (resource competition, antagonism, spatial crowding, and host immune and chemical barriers) and facilitative forces (niche vacancy, cross-feeding, and transient permissive windows). We further define a niche tension index (NTI) as a quantitative framework to estimate engraftment permissiveness across space, time, and host contexts. We synthesize evidence showing that niche tension is structured by gut transit, pH, oxygen gradients, diet, antibiotics, and host factors, including sex and hormonal state. Finally, we outline design rules for precision probiotics, including niche preconditioning, cooperative guild construction, sex-aware stratification, and data-driven prediction tools, to improve reproducibility and clinical efficacy.